Io biotech to present at the 45th annual cowen health care conference

Presentation will include an update on the development and launch preparations of cylembio™ (imsapepimut and etimupepimut, adjuvanted) new york, feb. 20, 2025 (globe newswire) -- io biotech (nasdaq: iobt), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that mai-britt zocca, phd, president and ceo, will present a company overview at the 45th annual cowen health care conference to be held march 3-5, 2025 in boston, ma. dr. zocca, joined by amy sullivan, cfo, and qasim ahmad, md, cmo, will also be hosting one-on-one investor meetings during the conference.
COWN Ratings Summary
COWN Quant Ranking